Acro Biomedical Co's market cap is currently ―. The company's EPS TTM is $-0.252; its P/E ratio is -0.42; Acro Biomedical Co is scheduled to report earnings on February 15, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Sep 22	Jun 22	Mar 22
Income Statement	-
Total Revenue	-	-	-	$ 0.00	$ 298.50K
Gross Profit	-	-	-	$ 0.00	$ 76.50K
EBIT	$ -3.20M	$ -4.00M	$ -4.01M	$ -4.00M	$ -3.93M
EBITDA	$ -72.04K	$ -76.25K	$ -82.72K	$ -4.00M	$ -3.93M
Net Income Common Stockholders	$ -3.20M	$ -4.00M	$ -4.01M	$ -4.00M	$ -3.93M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 2.68K	$ 322.00	$ 16.19K	$ 12.11K	$ 357.67K
Total Assets	$ 539.15K	$ 656.94K	$ 643.65K	$ 669.33K	$ 728.59K
Total Debt	$ 12.99K	$ 19.39K	$ 31.99K	$ 38.20K	$ 44.35K
Net Debt	$ 10.31K	$ 19.06K	$ 15.80K	$ 26.09K	$ -313.32K
Total Liabilities	$ 199.49K	$ 246.03K	$ 151.48K	$ 94.44K	$ 85.38K
Stockholders Equity	$ 339.65K	$ 410.90K	$ 492.16K	$ 574.89K	$ 643.22K
Cash Flow	-
Free Cash Flow	$ 2.25K	$ -5.57K	$ -53.27K	$ -345.78K	$ 262.13K
Operating Cash Flow	$ 2.25K	$ -5.57K	$ -53.27K	$ -345.78K	$ 262.13K
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	$ 108.00	$ 36.00	$ 57.35K	$ 216.00	$ 288.00

Currency in USD

Acro Biomedical Co Earnings and Revenue History

Income Statement >

Acro Biomedical Co Debt to Assets

Balance Sheet >

Acro Biomedical Co Cash Flow

Cash Flow >

Acro Biomedical Co Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing